Novartis (NVS) Tops Q2 EPS by 23c; offers outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St set to open lower as oil jump, high yields fuel inflation concerns
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Goldman Sachs sees 18% upside for Palantir on sovereign AI growth
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Citi names 5 top chip picks ahead of Q3 earnings
Tweet
Share
E-mail
Get Alerts NVS Hot Sheet
Join SI Premium – FREE
Novartis (NYSE: NVS) reported Q2 EPS of $2.41, $0.23 better than the analyst estimate of $2.18. Revenue for the quarter came in at $14.41 billion versus the consensus estimate of $14.17 billion.
Outlook
Net sales expected to grow low single-digit (vs. estimated growth of 0.41% Y/Y) and core operating income expected to decline low single-digit.
For earnings history and earnings-related data on Novartis (NVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novagold Resources, Inc. (NG) Misses Q3 EPS by 2c
- AmerX Starts CrowdStrike (CRWD) at Underweight
- Astera Labs launches PCIe 7 signal conditioning portfolio
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
